Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk prediction model for hypoxemia during painless gastroscopy with ciprofol sedation
ChiCTR2400090759Phase 4Completed
- Sponsor
- General Hospital of Eastern Military Command
- Start
- Oct 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol in None, sponsored by General Hospital of Eastern Military Command. Primary endpoint: Hypoxemia during gastroscopy. Started Oct 2024; status: completed.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2400090759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090759.